Paid Clinical Trials in Connecticut

Connecticut has 1,295 paid clinical trials enrolling now across cities including New Haven, Hartford and Stamford. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 11, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

1,144 clinical trials

Get a weekly email when new trials open in New Haven, CT.

Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies

for Multiple System Atrophy (MSA)

1 location in New Haven

Sponsor: MODAG GmbH

Sex: All·Age: 50 - 80·Accepts healthy volunteers

Code: NCT07640555·EARLY_Phase 1·Recruiting·Listed Jun 2026

Apply to this trial

Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomography (PET) Radiotracers in Adult Healthy Volunteers

for Healthy Adult

1 location in New Haven

Sponsor: MODAG GmbH

Sex: All·Age: 18 - 60·Accepts healthy volunteers

Code: NCT07617688·EARLY_Phase 1·Recruiting·Listed Jun 2026

Apply to this trial

A Study of HLD-0117 in Patients With Metastatic Breast Cancer

for Metastatic Breast Cancer

Sites in New Haven +5 more locations

Sponsor: Janssen Research & Development, LLC

Sex: Female·Age: 18+

Code: NCT07524855·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

for Non-Small-Cell Lung

Sites in New Haven, Trumbull +9 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07519655·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

for Advanced Microsatellite Stable Colorectal Cancer

Drug: Nivolumab

Sites in North Haven +4 more locations

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT07527858·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study

for Neovascular Age-Related Macular Degeneration (nAMD)

Sites in Waterford +7 more locations

Sponsor: Ocular Therapeutix, Inc.

Sex: All·Age: 50+

Code: NCT07516132·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

for Non-small Cell Lung Cancer

Sites in New Haven +11 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07513376·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy

for Relapsed or Refractory Large B-cell Lymphoma

Drug: KITE-753

Sites in New Haven +13 more locations

Sponsor: Kite, A Gilead Company

Sex: All·Age: 18+

Code: NCT07479797·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

A Phase 1 Study of D3S-003 as Monotherapy in Participants With Advanced Solid Tumors With a KRAS p.G12D Mutation.

for KRAS P.G12D

Drug: D3S-003

Sites in New Haven +2 more locations

Sponsor: D3 Bio (Wuxi) Co., Ltd

Sex: All·Age: 18+

Code: NCT07456046·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

for Primary Immune Thrombocytopenia (ITP)

Drug: Ianalumab

Sites in Stamford +12 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07421167·Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

A Study of GEN1106 in Participants With Solid Tumors

for Solid Tumors

Drug: GEN1106

Sites in New Haven +4 more locations

Sponsor: Genmab

Sex: All·Age: 18+

Code: NCT07416123·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome

for Netherton Syndrome

Sites in New Haven +4 more locations

Sponsor: Quoin Pharmaceuticals

Sex: All·Age: 4+

Code: NCT07538583·Phase 2, Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)

for T Cell Malignancies

Sites in New Haven +5 more locations

Sponsor: Electra Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT07465835·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)

for Angina Pectoris

Sites in New Haven +2 more locations

Sponsor: VahatiCor, Inc.

Sex: All·Age: 18+

Code: NCT07449325·Recruiting·Listed Mar 2026

Apply to this trial

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

for Advanced Solid Tumors

Drug: Ivonescimab

Sites in Norwich +8 more locations

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT07397338·Phase 1, Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

Study of NTX-2001 on Alcohol Consumption in Alcohol Use Disorder

for Alcohol Use Disorder

1 location in New Haven

Sponsor: Newleos Therapeutics, Inc.

Sex: All·Age: 21 - 60

Code: NCT07520292·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Drug: GEN1079

Sites in New Haven +2 more locations

Sponsor: Genmab

Sex: All·Age: 18+

Code: NCT07387068·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

for Advanced Solid Tumor, Adult

Sites in New Haven +14 more locations

Sponsor: Cogent Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07361562·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults

for Healthy Adults

1 location in New Haven

Sponsor: Pfizer

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07597928·Phase 1·Recruiting·Listed May 2026

Apply to this trial

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

for Advanced Solid Tumors

Sites in New Haven +3 more locations

Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All·Age: 18+

Code: NCT07360314·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections

for Colorectal Anastomosis

Sites in New Haven +8 more locations

Sponsor: Medtronic - MITG

Sex: All·Age: 18+

Code: NCT07351071·Recruiting·Listed Jan 2026

Apply to this trial

First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors

for Solid Tumors (Phase 1)

Sites in New Haven +2 more locations

Sponsor: Adcendo ApS

Sex: All·Age: 18+

Code: NCT07362888·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

for Primary Myelofibrosis (PMF)

Drug: Ruxolitinib

Sites in New Haven +7 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07357727·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

for Solid Tumors

Sites in New Haven +5 more locations

Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All·Age: 18+

Code: NCT07374848·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

for Non-small Cell Lung Cancer (NSCLC)

Sites in New Haven +8 more locations

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT07349537·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in New Haven +4 more locations

Sponsor: Ottimo Pharma Limited

Sex: All·Age: 18+

Code: NCT07266428·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer

for HPV Infection

Sites in New Haven +2 more locations

Sponsor: Qurasense

Sex: Female·Age: 25+·Accepts healthy volunteers

Code: NCT07281599·Recruiting·Listed Dec 2025

Apply to this trial

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

for Locally Advanced Solid Tumor

Sites in New Haven +5 more locations

Sponsor: Ipsen

Sex: All·Age: 18+

Code: NCT07213817·Phase 1, Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

for Platinum-resistant Ovarian Cancer

Sites in New Haven +6 more locations

Sponsor: Stemline Therapeutics, Inc.

Sex: Female·Age: 18+

Code: NCT07226427·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in New Haven +6 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT07226349·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

for Breast Cancer

Sites in New Haven +5 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT07222267·Phase 1·Recruiting·Listed Oct 2025

Apply to this trial

M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

for Advanced Solid Tumor

Sites in New Haven +2 more locations

Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All·Age: 18+

Code: NCT07166601·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program

for Glycogen Storage Disease Type Ia

Sites in Hartford +8 more locations

Sponsor: Ultragenyx Pharmaceutical Inc

Sex: All·Age: 2+

Code: NCT06636383·Recruiting·Listed Oct 2024

Apply to this trial

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

for Advanced Prostate Cancer

Sites in New Haven +4 more locations

Sponsor: Genentech, Inc.

Sex: Male·Age: 18+

Code: NCT05800665·Phase 1·Recruiting·Listed Apr 2023

Apply to this trial

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

for Age-Related Macular Degeneration

Sites in Manchester +6 more locations

Sponsor: i-Lumen Scientific AUS PTY LTD

Sex: All·Age: 60+

Code: NCT06662162·Recruiting·Listed Oct 2024

Apply to this trial

Molecular Indicators of Systematic Fitness

for Healthy Adult

1 location in New Haven

Sponsor: VO Health, Inc.

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07393841·Recruiting·Listed Feb 2026

Apply to this trial

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer

Sites in New Haven +10 more locations

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT07111520·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)

for Osteogenesis Imperfecta (OI)

Sites in New Haven +8 more locations

Sponsor: Angitia Incorporated Limited

Sex: All·Age: 18 - 75

Code: NCT07062588·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

EVERO Drug-coated Balloon (DCB) Randomized Trial

for Peripheral Vascular Disease

Sites in New Haven +8 more locations

Sponsor: Cook Research Incorporated

Sex: All·Age: 18+

Code: NCT07144150·Recruiting·Listed Aug 2025

Apply to this trial

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

for Colorectal Cancer

Sites in New Haven +12 more locations

Sponsor: Criterium, Inc.

Sex: All·Age: 18+

Code: NCT06992258·Phase 2·Recruiting·Listed May 2025

Apply to this trial